Abiopharma

Organon anuncia acordo para alienar seu sistema JADA® por até US$ 465 milhões à Laborie

Organon anuncia un acuerdo para vender su sistema JADA® a Laborie por un monto de hasta $465 millones

Organon conclut un accord de cession de son système JADA® à Laborie pour un montant pouvant atteindre 465 millions de dollars

Teva Pharmaceutical Industries Ltd. - AUSTEDO®(deutetrabenazine) tablets and AUSTEDO XR®(deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

Rosen Law Firm Urges Inspire Medical Systems, Inc. (NYSE: INSP) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

Fortrea Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

Stockholder Alert: Robbins LLP Informs Investors of the Inspire Medical Systems, Inc. Class Action Lawsuit

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Notification from BriaCell Therapeutics Corp.